Does nebivolol prevent contrast-induced nephropathy in humans Full Text
Clinical Cardiology,  Clinical Article

Gunebakmaz O et al. – Pretreatment with nebivolol is protective against nephrotoxic effects of contrast media.

Methods
  • The present study enrolled 120 patients scheduled for coronary angiography and ventriculography.
  • All patients were hydrated with intravenous isotonic saline.
  • The patients in group I received 600 mg N–acetylcysteine every 12 hours for 4 days.
  • The patients in group II received 5 mg nebivolol every 24 hours for 4 days.
  • The patients in group III were only hydrated.
  • The primary endpoint was the occurrence of CIN.
  • The secondary endpoint was the change in serum creatinine (Cr) levels at 2 days and 5 days after the contrast exposure.

Results
  • Nine (22.5%) patients in group I developed CIN, as did 8 patients (20.0%) in group II and 11 patients (27.5%) in group III (P = 0.72).
  • Changes in mean Cr level from baseline to day 2 were not statistically significant in all groups.
  • However, authors detected a statistically significant increase in mean Cr levels at day 5 compared with baseline levels in group I and group III (from 1.42 ± 0.13 to 1.52 ± 0.26, p2 = 0.02; and from 1.43 ± 0.14 to 1.55 ± 0.30, p2 = 0.01, respectively).
  • Although an increase was detected in mean Cr level from baseline to the 5–day Cr level in group II, this did not reach statistical significance (from 1.40 ± 0.12 to 1.48 ± 0.23, P = 0.06).

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Family Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Family Medicine Articles

1 Effect of caffeine on exercise capacity and function in prostate cancer survivors Medicine and Science in Sports and Exercise, July 9, 2014    Clinical Article

2 Circumcision plus antibiotic, anti-inflammatory, and α-blocker therapy for the treatment for chronic prostatitis/chronic pelvic pain syndrome: A prospective, randomized, multicenter trial World Journal of Urology, July 16, 2014    Clinical Article

3 Changes in circulating leptin levels during acute stress and associations with craving in abstinent smokers: A preliminary investigation Psychoneuroendocrinology, June 20, 2014    Clinical Article

4 Vasectomy may increase risk of aggressive prostate cancer Harvard Gazette - Health News, July 11, 2014

5 Treating concurrent chronic low back pain and depression with low-dose venlafaxine: an initial identification of easy-to-use clinical predictors of early response Pain Medicine, July 8, 2014    Clinical Article

6 Physical activity motivation mediates the association between depression symptoms and moderate-to-vigorous physical activity Preventive Medicine, July 2, 2014    Clinical Article

7 Yoga as an adjunctive treatment for posttraumatic stress disorder: a randomized controlled trial The Journal of Clinical Psychiatry, July 7, 2014    Clinical Article

8 Biopsy characteristics in men with a preoperative diagnosis of prostatic adenocarcinoma with high Gleason Score (GS = 8-10) predict pathologic outcome in radical prostatectomy Human Pathology, July 22, 2014    Review Article

9 Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications BMJ, July 3, 2014    Evidence Based Medicine

10 Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22,000 individuals American Journal of Clinical Nutrition, July 8, 2014    Evidence Based Medicine

11 Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96–02/AUO AP 09/95 Trial Full Text European Urology, July 18, 2014    Free full text    Clinical Article

12 Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study Journal of Affective Disorders, July 16, 2014    Clinical Article

13 Tea consumption and leukemia risk: A meta-analysis Tumor Biology, February 12, 2014    Evidence Based Medicine    Clinical Article

14 The effect of green tea on blood pressure and lipid profile: A systematic review and meta-analysis of randomized clinical trials Nutrition, Metabolism & Cardiovascular Diseases, March 27, 2014    Evidence Based Medicine    Review Article

15 Plasmakinetic enucleation of the prostate compared with open prostatectomy for prostates larger than 100 grams: A randomized noninferiority controlled trial with long-term results at 6 years Full Text European Urology, July 28, 2014    Free full text    Clinical Article

16 Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies CNS Spectrums, July 1, 2014    Clinical Article

17 Tea consumption and the risk of five major cancers: A dose-response meta-analysis of prospective studies Full Text BMC Cancer, March 18, 2014    Free full text    Evidence Based Medicine    Review Article

18 Prospective study of breakfast eating and incident coronary heart disease in a cohort of male US health professionals Full Text Circulation, July 24, 2013    Free full text    Clinical Article

19 Coffee consumption and prostate cancer risk: An updated meta-analysis Cancer Causes and Control, March 3, 2014    Evidence Based Medicine    Clinical Article

20 A prospective, blinded comparison of magnetic resonance (MR) imaging–ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: The PROFUS trial Full Text European Urology, July 14, 2014    Free full text    Clinical Article

Indexed Journals in Family Medicine: American Family Physician, Archives of Family Med, Annals of Family Medmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close